rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

C. Eric Winzer

Director

Company insider

Files Form 4 as: Director, Cytomedix Inc Com New; EVP & Chief Financial Officer, Avalon Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
32
Buys
1
Sells
0
Bought
$25K
Sold
$0
Companies
2
Companies where not an officer
1
First trade
2 Jul 2007
Last trade
30 Jun 2026
Last filed
2 Jul 2026

Companies traded

Where they are an officer
Avalon PharmaceuticalsOfficer · last 22 Aug 20080 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
Cytomedix Inc Com NewDirector · Medical Devices · last 30 Jun 20261 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month. 1 lines have no legible date and are left out.

Every trade

TradedCompanyWhatAmount
30 Jun 2026filed 2 Jul 2026Cytomedix Inc Com NewMedical DevicesSEC FORM 4 Code M$40K40,000 at $1.00filing
30 Jun 2026filed 2 Jul 2026Cytomedix Inc Com NewMedical DevicesSEC FORM 4 Code F$40K39,604 at $1.01filing
30 Jun 2026filed 2 Jul 2026Cytomedix Inc Com Newoption or derivative · Medical DevicesSEC FORM 4 Code M—40,000 at $0.00filing
30 Jun 2026filed 2 Jul 2026Nuo Therapeuticsoption or derivativeSEC FORM 4 Code M—40,000 at $0.00filing
30 Jun 2026filed 2 Jul 2026Nuo TherapeuticsSEC FORM 4 Code M$40K40,000 at $1.00filing
30 Jun 2026filed 2 Jul 2026Nuo TherapeuticsSEC FORM 4 Code F$40K39,604 at $1.01filing
29 Jun 2026filed 2 Jul 2026Nuo Therapeuticsoption or derivativeSEC FORM 4 Code A—30,000 at $0.00filing
29 Jun 2026filed 2 Jul 2026Cytomedix Inc Com Newoption or derivative · Medical DevicesSEC FORM 4 Code A—30,000 at $0.00filing
—filed 22 Dec 2025Nuo Therapeuticsoption or derivativeSEC FORM 4 Code M—68,750 at $0.00filing
17 Dec 2025filed 22 Dec 2025Nuo TherapeuticsSEC FORM 4 Code M$28K68,750 at $0.40filing
17 Dec 2025filed 22 Dec 2025Nuo TherapeuticsSEC FORM 4 Code F$28K13,750 at $2.00filing
1 Aug 2025filed 4 Aug 2025Nuo TherapeuticsSEC FORM 4 Code M$48K120,313 at $0.40filing
1 Aug 2025filed 4 Aug 2025Nuo TherapeuticsSEC FORM 4 Code F$48K27,659 at $1.74filing
1 Aug 2025filed 4 Aug 2025Nuo TherapeuticsSEC FORM 4 Code M$48K120,313 at $0.40filing
1 Aug 2025filed 4 Aug 2025Nuo TherapeuticsSEC FORM 4 Code F$48K27,659 at $1.74filing
17 Jul 2024filed 22 Jul 2024Nuo Therapeuticsoption or derivativeSEC FORM 4 Code A$13K40,000 at $0.33filing
4 Mar 2022filed 26 Apr 2022Nuo Therapeuticsoption or derivativeSEC FORM 4 Code A—36,666 at $0.00filing
4 Mar 2022filed 26 Apr 2022Nuo Therapeuticsoption or derivativeSEC FORM 4 Code A—75,000 at $0.00filing
31 Dec 2018filed 3 Jan 2019Nuo Therapeuticsoption or derivativeSEC FORM 4 Code A—68,750 at $0.00filing
9 Aug 2018filed 4 Aug 2025Nuo Therapeuticsoption or derivativeSEC FORM 4 Code M—120,313 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.